
Opinion|Videos|December 13, 2023
The Grading and Management of Early and Late Adverse Events
Author(s)Justin LaPorte, PharmD, BCOP
Justin LaPorte, PharmD, BCOP, presents information on the grading and management of early and late adverse events.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
3
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
4
Dr Tolaney on SG + Pembrolizumab Biomarker Data in First-Line mTNBC
5































